
Utah Medical Products UTMD
$ 63.28
1.02%
Quarterly report 2025-Q3
added 11-14-2025
Utah Medical Products Operating Cash Flow 2011-2026 | UTMD
Annual Operating Cash Flow Utah Medical Products
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 22.3 M | 21.1 M | 21.2 M | 20.1 M | 17.1 M | 16.8 M | 16.9 M | 14.5 M | 13.8 M | 15.4 M | 12.3 M | 13.6 M | 11.4 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 22.3 M | 11.4 M | 16.7 M |
Quarterly Operating Cash Flow Utah Medical Products
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | 4.46 M | - | - | - | 5.28 M | - | - | - | 6.92 M | - | 15.5 M | 9.88 M | 5.05 M | - | 16.2 M | 10.2 M | 5.53 M | - | 14.4 M | 9.35 M | 5.67 M | - | 11.4 M | 5.04 M | 3.36 M | - | 12.4 M | 7.75 M | 3.77 M | - | 12.3 M | 7.74 M | 4.31 M | - | 11.1 M | 7.76 M | 4.15 M | - | 9.9 M | 5.73 M | 2.24 M | - | 10.9 M | 5.76 M | 1.92 M | - | 9.06 M | 5.04 M | 2.72 M | - | 10.5 M | 6.54 M | 3.43 M | - | 7.86 M | 4.45 M | 2.76 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 16.2 M | 1.92 M | 7.39 M |
Operating Cash Flow of other stocks in the Medical instruments industry
| Issuer | Operating Cash Flow | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
AtriCure
ATRC
|
57.3 M | $ 29.85 | 1.05 % | $ 1.43 B | ||
|
AngioDynamics
ANGO
|
-10.1 M | $ 10.6 | -1.03 % | $ 433 M | ||
|
Atrion Corporation
ATRI
|
20 K | - | - | $ 810 M | ||
|
Harvard Bioscience
HBIO
|
14 M | $ 0.47 | -4.15 % | $ 19.9 M | ||
|
Alcon
ALC
|
1.34 B | $ 77.32 | -1.5 % | $ 40.4 B | ||
|
ICU Medical
ICUI
|
180 M | $ 125.85 | -2.28 % | $ 3.1 B | ||
|
InfuSystem Holdings
INFU
|
17.5 M | $ 9.31 | -0.85 % | $ 192 M | ||
|
iRhythm Technologies
IRTC
|
80.9 M | $ 113.0 | -1.46 % | $ 3.62 B | ||
|
Intuitive Surgical
ISRG
|
3.03 B | $ 472.16 | -1.48 % | $ 169 B | ||
|
The Cooper Companies
COO
|
796 M | $ 69.92 | -2.24 % | $ 13.9 B | ||
|
Glaukos Corporation
GKOS
|
-57.8 M | $ 97.02 | -0.79 % | $ 4.7 B | ||
|
Becton, Dickinson and Company
BDX
|
3.33 B | $ 159.36 | -0.17 % | $ 45.8 B | ||
|
Haemonetics Corporation
HAE
|
182 M | $ 59.92 | 0.72 % | $ 3.02 B | ||
|
electroCore
ECOR
|
-14.7 M | $ 6.14 | -3.0 % | $ 33.9 K | ||
|
Masimo Corporation
MASI
|
196 M | $ 175.49 | -0.01 % | $ 9.35 B | ||
|
Isoray
ISR
|
-18.3 M | - | 0.03 % | $ 108 M | ||
|
Predictive Oncology
POAI
|
-12.4 M | - | - | $ 31.1 M | ||
|
Ekso Bionics Holdings
EKSO
|
-11.8 M | $ 11.56 | -2.12 % | $ 28 M | ||
|
Repro Med Systems
KRMD
|
462 K | $ 4.28 | -0.7 % | $ 198 M | ||
|
Baxter International
BAX
|
845 M | $ 17.4 | -3.36 % | $ 8.93 B | ||
|
BioLife Solutions
BLFS
|
8.43 M | $ 18.36 | 1.16 % | $ 846 M | ||
|
Nephros
NEPH
|
827 K | $ 3.5 | -7.89 % | $ 36.4 M | ||
|
ResMed
RMD
|
351 M | $ 230.84 | -0.68 % | $ 33.7 B | ||
|
Retractable Technologies
RVP
|
-11.6 M | $ 0.71 | 2.62 % | $ 21.3 M | ||
|
NeuroMetrix
NURO
|
-7.13 M | - | 5.05 % | $ 9.02 M | ||
|
Merit Medical Systems
MMSI
|
297 M | $ 69.95 | 2.61 % | $ 4.14 B | ||
|
Envista Holdings Corporation
NVST
|
276 M | $ 24.61 | -3.26 % | $ 4.13 B | ||
|
STAAR Surgical Company
STAA
|
-34.2 M | $ 18.84 | 2.45 % | $ 934 M | ||
|
Stereotaxis
STXS
|
-13.7 M | $ 1.89 | 0.27 % | $ 172 M | ||
|
OraSure Technologies
OSUR
|
-49 M | $ 2.97 | -3.88 % | $ 218 M | ||
|
LeMaitre Vascular
LMAT
|
81.3 M | $ 108.06 | 1.43 % | $ 2.45 B | ||
|
Pro-Dex
PDEX
|
-1.68 M | $ 48.46 | 3.5 % | $ 159 M | ||
|
Microbot Medical
MBOT
|
-8.53 M | $ 2.69 | -1.47 % | $ 27.4 M | ||
|
West Pharmaceutical Services
WST
|
755 M | $ 235.46 | 1.89 % | $ 17 B | ||
|
Repligen Corporation
RGEN
|
114 M | $ 114.2 | 0.39 % | $ 6.36 M | ||
|
DENTSPLY SIRONA
XRAY
|
235 M | $ 11.54 | -2.2 % | $ 2.3 B | ||
|
Pulse Biosciences
PLSE
|
-54.1 M | $ 21.57 | 1.27 % | $ 1.45 B | ||
|
STERIS plc
STE
|
1.15 B | $ 214.57 | 1.05 % | $ 21.2 B | ||
|
Milestone Scientific
MLSS
|
-2.92 M | $ 0.28 | -3.75 % | $ 22.3 M |